Edward Holland

Summary

Affiliation: University of Cincinnati
Country: USA

Publications

  1. doi The AcrySof Toric intraocular lens in subjects with cataracts and corneal astigmatism: a randomized, subject-masked, parallel-group, 1-year study
    Edward Holland
    Cincinnati Eye Institute, University of Cincinnati, Cincinnati, Ohio, USA
    Ophthalmology 117:2104-11. 2010
  2. doi Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation
    Edward J Holland
    Cincinnati Eye Institute, OH, USA
    Cornea 28:1139-43. 2009
  3. ncbi Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique
    Edward J Holland
    Cincinnati Eye Institute, University of Cincinnati, Cincinnati, Ohio 45242, USA
    Ophthalmology 110:125-30. 2003
  4. doi Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty
    Edward J Holland
    Cincinnati Eye Institute, Edgewood, KY, USA
    Cornea 27:314-9. 2008
  5. doi Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers
    Edward J Holland
    Cincinnati Eye Institute and University of Cincinnati, Cincinnati, OH, USA
    Cornea 27:50-5. 2008
  6. ncbi The ocular penetration of levofloxacin 1.5% and gatifloxacin 0.3% ophthalmic solutions in subjects undergoing corneal transplant surgery
    Edward J Holland
    Cincinnati Eye Institute, Cincinnati, OH, USA
    Curr Med Res Opin 23:2955-60. 2007
  7. ncbi The Paton lecture: Ocular surface transplantation: 10 years' experience
    Edward J Holland
    Department of Ophthalmology, University of Cincinnati, and Cornea Service, Cincinnati Eye Institute, Cincinnati, OH 45242, USA
    Cornea 23:425-31. 2004
  8. pmc Resolution of autoimmune polyglandular syndrome-associated keratopathy with keratolimbal stem cell transplantation: case report and historical literature review
    Manan Shah
    Cincinnati Eye Institute, Edgewood, KY 41017, USA
    Cornea 26:632-5. 2007
  9. ncbi Concentrations of levofloxacin, ofloxacin, and ciprofloxacin in human corneal stromal tissue and aqueous humor after topical administration
    Daniel P Healy
    Cincinnati Eye Institute, Cincinnati, OH 45242, USA
    Cornea 23:255-63. 2004
  10. ncbi Ocular surface reconstruction: limbal stem cell transplantation
    Joung Y Kim
    Cincinnati Eye Institute, Cincinnati, OH, USA
    Ophthalmol Clin North Am 16:67-77. 2003

Collaborators

Detail Information

Publications38

  1. doi The AcrySof Toric intraocular lens in subjects with cataracts and corneal astigmatism: a randomized, subject-masked, parallel-group, 1-year study
    Edward Holland
    Cincinnati Eye Institute, University of Cincinnati, Cincinnati, Ohio, USA
    Ophthalmology 117:2104-11. 2010
    ..Fort Worth, TX) in subjects with cataracts and preexisting corneal astigmatism...
  2. doi Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation
    Edward J Holland
    Cincinnati Eye Institute, OH, USA
    Cornea 28:1139-43. 2009
    ..5% ophthalmic suspension as second-line rescue therapy after corneal transplantation...
  3. ncbi Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique
    Edward J Holland
    Cincinnati Eye Institute, University of Cincinnati, Cincinnati, Ohio 45242, USA
    Ophthalmology 110:125-30. 2003
    ..We evaluated the role of keratolimbal allograft (KLAL), a stem cell transplantation technique, for the treatment of patients with aniridic keratopathy...
  4. doi Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty
    Edward J Holland
    Cincinnati Eye Institute, Edgewood, KY, USA
    Cornea 27:314-9. 2008
    ..To compare the corneal and aqueous penetration and pharmacokinetics of gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions and their effect on corneal reepithelialization after penetrating keratoplasty...
  5. doi Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers
    Edward J Holland
    Cincinnati Eye Institute and University of Cincinnati, Cincinnati, OH, USA
    Cornea 27:50-5. 2008
    ..To compare the steroid-induced intraocular pressure (IOP) and other ocular adverse effects of loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension with those of dexamethasone 0.1% and tobramycin 0.3% ophthalmic suspension...
  6. ncbi The ocular penetration of levofloxacin 1.5% and gatifloxacin 0.3% ophthalmic solutions in subjects undergoing corneal transplant surgery
    Edward J Holland
    Cincinnati Eye Institute, Cincinnati, OH, USA
    Curr Med Res Opin 23:2955-60. 2007
    ..To compare corneal tissue and aqueous humor concentrations of levofloxacin 1.5% and gatifloxacin 0.3% ophthalmic solutions after topical dosing...
  7. ncbi The Paton lecture: Ocular surface transplantation: 10 years' experience
    Edward J Holland
    Department of Ophthalmology, University of Cincinnati, and Cornea Service, Cincinnati Eye Institute, Cincinnati, OH 45242, USA
    Cornea 23:425-31. 2004
  8. pmc Resolution of autoimmune polyglandular syndrome-associated keratopathy with keratolimbal stem cell transplantation: case report and historical literature review
    Manan Shah
    Cincinnati Eye Institute, Edgewood, KY 41017, USA
    Cornea 26:632-5. 2007
    ..To describe the presentation and treatment of a case of autoimmune polyglandular syndrome type 1 (APS1)-associated keratopathy and to review the associated literature...
  9. ncbi Concentrations of levofloxacin, ofloxacin, and ciprofloxacin in human corneal stromal tissue and aqueous humor after topical administration
    Daniel P Healy
    Cincinnati Eye Institute, Cincinnati, OH 45242, USA
    Cornea 23:255-63. 2004
    ..To evaluate the penetration of commercially available levofloxacin 0.5%, ofloxacin 0.3%, and ciprofloxacin 0.3% topical ophthalmic solutions in human corneal stromal and aqueous humor tissues...
  10. ncbi Ocular surface reconstruction: limbal stem cell transplantation
    Joung Y Kim
    Cincinnati Eye Institute, Cincinnati, OH, USA
    Ophthalmol Clin North Am 16:67-77. 2003
    ..Developments in the management of limbal stem cell disease are progressing rapidly, and the long-term outlook for patients with this challenging disease continues to improve...
  11. ncbi Ocular surface reconstruction in a patient with complete ankyloblepharon resulting from stevens-johnson syndrome
    Michael L Nordlund
    Cincinnati Eye Institute and Department of Ophthalmology, University of Cincinnati, OH 45242, USA
    Arch Ophthalmol 122:934-5. 2004
  12. ncbi Pressure-induced interface keratitis: a late complication following LASIK
    Michael L Nordlund
    Cincinnati Eye Institute and Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, OH 45242, USA
    Cornea 23:225-34. 2004
    ....
  13. ncbi Anterior stromal puncture in the treatment of loose epithelium after LASIK
    Harilaos S Brilakis
    University of Cincinnati and Cincinnati Eye Institute, Cincinnati, Ohio 45242, USA
    J Refract Surg 22:103-5. 2006
    ..To describe anterior stromal puncture, with or without a bandage contact lens, as a means to treat LASIK epithelial defects and potentially reduce the likelihood of secondary diffuse lamellar keratitis (DLK)...
  14. ncbi A progressive anterior fibrosis syndrome in patients with postsurgical congenital aniridia
    Julie H Tsai
    University of Cincinnati and Cincinnati Eye Institute, Cincinnati, Ohio, USA
    Am J Ophthalmol 140:1075-9. 2005
    ..To report the characteristics of a newly recognized clinical entity in congenital aniridia that we have termed aniridic fibrosis syndrome...
  15. pmc Endothelial cell density to predict endothelial graft failure after penetrating keratoplasty
    Jonathan H Lass
    Department of Ophthalmology and Visual Sciences, Case Western Reserve University and University Hospitals Eye Institute, Cleveland, Ohio, USA
    Arch Ophthalmol 128:63-9. 2010
    ....
  16. ncbi Recurrence of Fuchs marginal keratitis within a lamellar graft
    Harilaos S Brilakis
    Department of Cornea and External Disease, Cincinnati Eye Institute, OH 45242, USA
    Cornea 23:639-40. 2004
    ..Two years after an initial lamellar keratoplasty, the pathology recurred within the graft. A repeat lamellar keratoplasty was performed, this time combined with a conjunctival autograft...
  17. ncbi Incidence and prevalence of glaucoma in severe ocular surface disease
    Julie H Tsai
    University of Cincinnati Cincinnati Eye Institute, Cincinnati, OH, USA
    Cornea 25:530-2. 2006
    ..To describe the incidence and prevalence of glaucoma in a patient population with severe ocular surface disease (OSD)...
  18. ncbi Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery
    Stephen S Lane
    J Cataract Refract Surg 33:53-8. 2007
    ..To determine whether nepafenac ophthalmic suspension 0.1% decreases the incidence and severity of inflammation and pain after cataract surgery with posterior chamber intraocular lens implantation...
  19. ncbi AlphaCor: Clinical outcomes
    Celia R Hicks
    Biomaterials Research Centre, Lions Eye Institute and Centre for Ophthalmology and Visual Science, University of Western Australia, Perth, Australia
    Cornea 25:1034-42. 2006
    ..To study the outcomes of AlphaCor implantation...
  20. ncbi Double-masked study of the effects of nepafenac 0.1% and ketorolac 0.4% on corneal epithelial wound healing and pain after photorefractive keratectomy
    Eric D Donnenfeld
    Ophthalmic Consultants of Long Island, Rockville Centre, New York 11570, USA
    Adv Ther 24:852-62. 2007
    ..4% provide postoperative pain relief after PRK surgery without associated adverse effects on corneal epithelial healing. Nepafenac 0.1% treatment may offer greater comfort upon instillation in patients who have undergone PRK...
  21. ncbi Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation
    Eric D Donnenfeld
    External Disease Cornea Department, Manhattan Eye, Ear and Throat Hospital, New York, New York, USA
    Ophthalmology 114:1653-62. 2007
    ..To evaluate the efficacy and ocular safety of bromfenac ophthalmic solution 0.09% (Xibrom) for the treatment of postoperative inflammation and reduction of ocular pain in subjects who have undergone cataract extraction (CE)...
  22. ncbi Clinical profile and early surgical complications in the Cornea Donor Study
    Mark J Mannis
    Cornea 25:164-70. 2006
    ..Baseline patient data, including indications for transplant, intraoperative complication rates, and early postoperative complication rates are described herein...
  23. ncbi Assessment of visual function after corneal transplantation: the quality of life and psychometric assessment after corneal transplantation (Q-PACT) study
    Flavia Mendes
    Massachusetts Eye and Ear Infirmary and Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts 02114, USA
    Am J Ophthalmol 135:785-93. 2003
    ..Many patients with successful corneal grafts have poor vision postoperatively. This study evaluates changes in vision-related quality of life after penetrating keratoplasty (PK)...
  24. ncbi Limbal stem cell deficiency
    Ali R Djalilian
    Ophthalmology 110:2071; author reply 2071-2. 2003
  25. ncbi Efficacy and safety of international donor sharing: a single-center, case-controlled study on corneal transplantation
    Jun Shimazaki
    The Department of Ophthalmology, Tokyo Dental College, 5 11 13 Sugano, Ichikawa shi, Chiba 272 8513, Japan
    Transplantation 78:216-20. 2004
    ..This single-center, case-controlled study was conducted to show the efficacy and safety of corneal transplantation using corneas from foreign donors...
  26. ncbi A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance
    Stephen C Pflugfelder
    Baylor College of Medicine, Houston, Texas, USA
    Am J Ophthalmol 138:444-57. 2004
    ..To evaluate loteprednol etabonate ophthalmic 0.5% suspension, versus placebo for treatment of the inflammatory component of keratoconjunctivitis sicca in patients with delayed tear clearance...
  27. ncbi Survival of donor epithelial cells after limbal stem cell transplantation
    Ali R Djalilian
    National Eye Institute, National Institutes of Health, Building 10, Room 10N112, 10 Center Drive, Bethesda, MD 20892, USA
    Invest Ophthalmol Vis Sci 46:803-7. 2005
    ..To determine the long-term fate of donor epithelial cells after limbal allograft transplantation...
  28. ncbi Baseline donor characteristics in the Cornea Donor Study
    Alan Sugar
    Cornea 24:389-96. 2005
    ..Characteristics of the donor population have been evaluated with respect to donor age, endothelial cell density, and death to preservation interval...
  29. ncbi Clinical application of living-related conjunctival-limbal allograft
    Kazuo Tsubota
    Department of Ophthalmology, Tokyo Dental College, Ichikawa shi, Chiba, Japan
    Am J Ophthalmol 133:134-5. 2002
    ..To report one successful case of conjunctival-limbal allograft for the treatment of a severe ocular surface disorder...
  30. ncbi Peripheral keratitis associated with chronic myelomonocytic leukemia
    Monika A Malecha
    Department of Ophthalmology, University of Tennessee Health Science Center, Memphis 38163, USA
    Cornea 21:723-4. 2002
    ..To describe a case of peripheral keratitis in a patient with an acute exacerbation of chronic myelomonocytic leukemia (CMML)...
  31. pmc Donor age and corneal endothelial cell loss 5 years after successful corneal transplantation. Specular microscopy ancillary study results
    Jonathan H Lass
    Cornea Donor Study Coordinating Center, Jaeb Center for Health Research, 15310 Amberly Drive, Suite 350, Tampa, FL 33647, USA
    Ophthalmology 115:627-632.e8. 2008
    ..To determine whether endothelial cell loss 5 years after successful corneal transplantation is related to the age of the donor...
  32. ncbi Correction of myopia and astigmatism after penetrating keratoplasty with laser in situ keratomileusis
    Monika A Malecha
    Department of Ophthalmology, University of Minnesota, Minneapolis, MN, USA
    Cornea 21:564-9. 2002
    ..We evaluated whether laser in situ keratomileusis (LASIK) was a safe and effective treatment for myopia and astigmatism after penetrating keratoplasty (PK)...
  33. pmc The effect of donor age on corneal transplantation outcome results of the cornea donor study
    Robin L Gal
    Society of Northeastern New York Lions Eye Bank of Albany, Albany, New York, USA
    Ophthalmology 115:620-626.e6. 2008
    ..To determine whether graft survival over a 5-year follow-up period using corneal tissue from donors older than 65 is similar to graft survival using corneas from younger donors...
  34. ncbi Bilateral herpetic keratoconjunctivitis
    Paula Márcia F Souza
    Department of Ophthalmology, University of Minnesota, 516 Delaware Street SE, Minneapolis, MN 55455, USA
    Ophthalmology 110:493-6. 2003
    ..To review the clinical characteristics and visual outcomes of patients with bilateral herpetic keratitis...
  35. ncbi Infectious keratitis after laser in situ keratomileusis: results of an ASCRS survey
    Renee Solomon
    Ophthalmic Consultants of Long Island, Rockville Centre, East Meadow, New York, USA
    J Cataract Refract Surg 29:2001-6. 2003
    ..Empiric therapy is not recommended as most of the organisms are opportunistic and not responsive to conventional therapy. Flap elevation and culturing should be performed when post-LASIK infectious keratitis is suspected...
  36. ncbi An evaluation of image quality and accuracy of eye bank measurement of donor cornea endothelial cell density in the Specular Microscopy Ancillary Study
    Jonathan H Lass
    Cornea Donor Study Coordinating Center, Jaeb Center for Health Research, 15310 Amberly Drive, Suite 350, Tampa, FL 33647, USA
    Ophthalmology 112:431-40. 2005
    ....
  37. ncbi Ectasia following laser in situ keratomileusis
    Edward J Holland
    J Cataract Refract Surg 31:2034. 2005
  38. ncbi ASCRS White Paper: Management of infectious keratitis following laser in situ keratomileusis
    Eric D Donnenfeld
    J Cataract Refract Surg 31:2008-11. 2005